Serveur d'exploration SRAS - Curation (Ncbi)

Index « Keywords » - entrée « Microbial Sensitivity Tests »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Microbial Interactions (physiology) < Microbial Sensitivity Tests < Microbial Sensitivity Tests (methods)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 51.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000037 (2003) Martin Enserink ; Gretchen VogelInfectious diseases. Deferring competition, global net closes in on SARS.
000777 (2004) S A Sattar [Canada]Microbicides and the environmental control of nosocomial viral infections.
000975 (2004) F. Chen [Hong Kong] ; K. H Chan [Hong Kong] ; Y. Jiang [Hong Kong] ; R. Y. T Kao [Hong Kong] ; H. T Lu [Hong Kong] ; K. W Fan [Hong Kong] ; V. C. C Cheng [Hong Kong] ; W. H. W Tsui [Hong Kong] ; I. F. N Hung [Hong Kong] ; T. S. W Lee [Hong Kong] ; Y. Guan [Hong Kong] ; J. S. M Peiris [Hong Kong] ; K. Y Yuen [Hong Kong]In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
000A90 (2004) Ling Yi ; Zhengquan Li ; Kehu Yuan ; Xiuxia Qu ; Jian Chen ; Guangwen Wang ; Hong Zhang ; Hongpeng Luo ; Lili Zhu ; Pengfei Jiang ; Lirong Chen ; Yan Shen ; Min Luo ; Guoying Zuo ; Jianhe Hu ; Deliang Duan ; Yuchun Nie ; Xuanling Shi ; Wei Wang ; Yang Han ; Taisheng Li ; Yuqing Liu ; Mingxiao Ding ; Hongkui Deng ; Xiaojie XuSmall Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells
000D46 (2005) Naoyuki Masuda [Japon] ; Osamu Yamamoto ; Masahiro Fujii ; Tetsuro Ohgami ; Jiro Fujiyasu ; Toru Kontani ; Ayako Moritomo ; Masaya Orita ; Hiroyuki Kurihara ; Hironobu Koga ; Shunji Kageyama ; Mitsuaki Ohta ; Hiroshi Inoue ; Toshifumi Hatta ; Masafumi Shintani ; Hiroshi Suzuki ; Kenji Sudo ; Yasuaki Shimizu ; Eiichi Kodama ; Masao Matsuoka ; Masatoshi Fujiwara ; Tomoyuki Yokota ; Shiro Shigeta ; Masanori BabaStudies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivatives.
000F38 (2005) Shi-You Li [République populaire de Chine] ; Cong Chen ; Hai-Qing Zhang ; Hai-Yan Guo ; Hui Wang ; Lin Wang ; Xiang Zhang ; Shi-Neng Hua ; Jun Yu ; Pei-Gen Xiao ; Rong-Song Li ; Xuehai TanIdentification of natural compounds with antiviral activities against SARS-associated coronavirus.
000F66 (2005) Jason Paragas [États-Unis] ; Lawrence M. Blatt ; Chris Hartmann ; John W. Huggins ; Tim P. EndyInterferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models.
000F68 (2005) Masayuki Saijo [Japon] ; Shigeru Morikawa ; Shuetsu Fukushi ; Tetsuya Mizutani ; Hideki Hasegawa ; Noriyo Nagata ; Naoko Iwata ; Ichiro KuraneInhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.
001294 (2006) Andrea J. Dooley [États-Unis] ; Nice Shindo ; Barbara Taggart ; Jewn-Giew Park ; Yuan-Ping PangFrom genome to drug lead: identification of a small-molecule inhibitor of the SARS virus.
001330 (2006) Pi-Hui Liang [Taïwan] ; Wei-Chieh Cheng ; Yi-Ling Lee ; Han-Pang Yu ; Ying-Ta Wu ; Yi-Ling Lin ; Chi-Huey WongNovel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis.
001473 (2006) Rolf Hilgenfeld [Allemagne] ; Ksenia PumporSometimes intermediates. Do the job!
001507 (2006) D-Q Wei [République populaire de Chine] ; R. Zhang ; Q-S Du ; W-N Gao ; Y. Li ; H. Gao ; S-Q Wang ; X. Zhang ; A-X Li ; S. Sirois ; K-C ChouAnti-SARS drug screening by molecular docking.
001612 (2006) Xiaoping Kang [République populaire de Chine] ; Bao-An Yang ; Yuyang Hu ; Hui Zhao ; Wei Xiong ; Yinhui Yang ; Bingyin Si ; Qingyu ZhuHuman neutralizing Fab molecules against severe acute respiratory syndrome coronavirus generated by phage display.
001809 (2006) Chung K. Chu [États-Unis] ; Srinivas Gadthula ; Xin Chen ; Hyunah Choo ; Sureyya Olgen ; Dale L. Barnard ; Robert W. SidwellAntiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV).
001993 (2007) F J U M. Van Der Meer [Pays-Bas] ; C A M. De Haan ; N M P. Schuurman ; B J Haijema ; W J Peumans ; E J M. Van Damme ; P L Delputte ; J. Balzarini ; H F EgberinkAntiviral activity of carbohydrate-binding agents against Nidovirales in cell culture.
001A52 (2007) Masahiro Ikejiri [Japon] ; Takayuki Ohshima ; Keizo Kato ; Masaaki Toyama ; Takayuki Murata ; Kunitada Shimotohno ; Tokumi Maruyama5'-O-masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents.
001C06 (2008) Monica R. Loizzo [Italie] ; Antoine M. Saab ; Rosa Tundis ; Giancarlo A. Statti ; Francesco Menichini ; Ilaria Lampronti ; Roberto Gambari ; Jindrich Cinatl ; Hans Wilhelm DoerrPhytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species.
001F85 (2009) Christine Dellanno [États-Unis] ; Quinn Vega ; Diane BoesenbergThe antiviral action of common household disinfectants and antiseptics against murine hepatitis virus, a potential surrogate for SARS coronavirus.
001F91 (2009) Robert F. ServiceAmerican Chemical Society fall meeting, 16-20 August, Washington, D.C. Sugary Achilles' heel raises hope for broad-acting antiviral drugs.
002419 (2012) Yan-Fei Qi [République populaire de Chine] ; Hong Zhang ; Juan Wang ; Yanfang Jiang ; Jinhua Li ; Ye Yuan ; Shiyao Zhang ; Kun Xu ; Yangguang Li ; Juan Li ; Junqi Niu ; Enbo WangIn vitro anti-hepatitis B and SARS virus activities of a titanium-substituted-heteropolytungstate.
002661 (2013) Adriaan H. De Wilde [Pays-Bas] ; V. Stalin Raj [Pays-Bas] ; Diede Oudshoorn [Pays-Bas] ; Theo M. Bestebroer [Pays-Bas] ; Stefan Van Nieuwkoop [Pays-Bas] ; Ronald W. A. L. Limpens [Pays-Bas] ; Clara C. Posthuma [Pays-Bas] ; Yvonne Van Der Meer [Pays-Bas] ; Montserrat Bárcena [Pays-Bas] ; Bart L. Haagmans [Pays-Bas] ; Eric J. Snijder [Pays-Bas] ; Bernadette G. Van Den Hoogen [Pays-Bas]MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Microbial Sensitivity Tests" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Microbial Sensitivity Tests" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Microbial Sensitivity Tests
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021